İnanc Mendilcioğlu Mendilcioğlu (İbrahim İnanç Mendilcioğlu, Inanc Mendilcioglu, Ibrahim Inanc Mendilcioglu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Low Birth Weight

Polycystic Ovary Syndrome

Tandem Mass Spectrometry

Top Venues

Obstetrics and gynecology international

Ginekologia polska

International journal of clinical practice

The journal of obstetrics and gynaecology research

This page only lists publications with an associated author ORCID identifier.

Publications

Fatma Ceren Guner, Murat Ozekinci, İnanc Mendilcioğlu Mendilcioğlu, Zeliha Kasabali
Reproductive Outcomes of Dual Trigger versus hCG Alone in Women Undergoing In Vitro Fertilization with Fresh Embryo Transfer Cycles. Obstetrics and gynecology international 2024 (2024)
Fatma Ceren Guner, Murat Ozekinci, İnanc Mendilcioğlu Mendilcioğlu, Zeliha Kasabali
Reproductive Outcomes of Dual Trigger versus hCG Alone in Women Undergoing In Vitro Fertilization with Fresh Embryo Transfer Cycles. Obstetrics and gynecology international 2024 (2024)
Doğukan Çopur, Ozlem K Ozyurt, Hülya Kandemir, Betil Ozhak, Dilara Ogunc, İnanc Mendilcioğlu Mendilcioğlu
Comparison of Polymerase Chain Reaction Method with Culture Method in Antenatal Group B Streptococcus Screening. Ginekologia polska (2024)
Hülya Kandemir, Gül Alkan Bülbül, Emine Kirtis, Selin Güney, Cem Yaşar Sanhal, İnanc Mendilcioğlu Mendilcioğlu
Evaluation of long-COVID symptoms in women infected with SARS-CoV-2 during pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2023)
Hakan Ongun, Kıymet Çelik, Sema Arayici, Nasuh Utku Dogan, İnanc Mendilcioğlu Mendilcioğlu, Ozlenen Ozkan, Omer Ozkan
Miracles of science: Birth after uterus transplantation. The journal of obstetrics and gynaecology research (2023)
Merve Erol Deniz, Alparslan Deniz, İnanc Mendilcioğlu Mendilcioğlu, Cem Yaşar Sanhal, Sebahat Özdem, Ikbal Ozen Kücükcetin, Hülya Kandemir
Serial measurement of soluble endoglin for risk assessment at the diagnosis of fetal growth restriction. International journal of clinical practice (2021)